First Trust Nasdaq Pharmaceuticals ETF (FTXH)

Assets	$19.34M
Expense Ratio	0.60%
PE Ratio	15.42
Shares Out	750,002
Dividend (ttm)	$0.38
Dividend Yield	1.48%
Ex-Dividend Date	Mar 21, 2024
Payout Ratio	22.81%
1-Year Return	-3.86%

Volume	1,159
Open	25.76
Previous Close	25.78
Day's Range	25.73 - 25.79
52-Week Low	23.85
52-Week High	28.41
Beta	0.60
Holdings	51
Inception Date	Sep 20, 2016

About FTXH

Fund Home Page

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: FTXH
• ETF Provider: First Trust
• Index Tracked: Nasdaq US Smart Pharmaceuticals Index

Top 10 Holdings

54.63% of assets

Name	Symbol	Weight
Merck & Co., Inc.	MRK	7.57%
Pfizer Inc.	PFE	7.35%
Bristol-Myers Squibb Company	BMY	7.24%
AbbVie Inc.	ABBV	7.17%
Johnson & Johnson	JNJ	6.89%
Eli Lilly and Company	LLY	3.83%
Amgen Inc.	AMGN	3.70%
Cardinal Health, Inc.	CAH	3.65%
United Therapeutics Corporation	UTHR	3.63%
Vertex Pharmaceuticals Incorporated	VRTX	3.59%

Dividends

Ex-Dividend	Amount	Pay Date
Mar 21, 2024	$0.0676	Mar 28, 2024
Dec 22, 2023	$0.1232	Dec 29, 2023
Sep 22, 2023	$0.0725	Sep 29, 2023
Jun 27, 2023	$0.1179	Jun 30, 2023
Mar 24, 2023	$0.1001	Mar 31, 2023
Dec 23, 2022	$0.1253	Dec 30, 2022